Ambrisentan-induced severe asymptomatic thrombocytopenia

Case Report

Dana Kigitovica ¹

¹Department of Internal Diseases, Riga Stradins University; Riga-Latvia
²Medical Faculty, Riga Stradins University; Riga-Latvia

Anatol J Cardiol 2020; 4(24): 285-286 PubMed ID: 33001057 DOI: 10.14744/AnatolJCardiol.2020.91376

Full Text PDF

Keywords: Pulmonary arterial hypertension, Ambrisentan, Thrombocytopenia